Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bioxyne Limited ( (AU:BXN) ) has shared an update.
Bioxyne Limited has announced a change in the interest of its director, Mr. Anthony Ho, involving the disposal of 1,500,000 ordinary shares valued at $43,500. This transaction, which involved an on-market sale and reallocation between accounts, reflects a strategic adjustment in the director’s holdings, potentially impacting investor perceptions and the company’s market dynamics.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company is known for its probiotic and immune health products, targeting both domestic and international markets.
Average Trading Volume: 3,873,822
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$86.59M
For a thorough assessment of BXN stock, go to TipRanks’ Stock Analysis page.